REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Walvax Biotechnology Co.,Ltd. Profile Updated: January 04, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

The company was restructured from Watson Biotechnology Co., Ltd. on June 23, 2009 with the unanimous agreement of all shareholders. Xinyong Zhonghe Accountant Agency verified the company’s capital and issued No. XYZH/2007SZA2032-2 Audit Report. On June 25,2009 the company registered its change in Yunnan Provincial Administration of Industry and Commerce and received "business license for enterprise legal person"..

Headquarters
No. 395, Kexin Road, High-tech Zone, Kunming City, Yunnan Province
Yuxi; Yunnan; Postal Code: 650101

Contact Details: Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.

Website: http://www.walvax.com

Basic Information
Total Employees:
Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.
Registered Capital:
Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.
Financial Auditors:
Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.
Incorporation Date:
January 16, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
2.16%
Purchase this report to view the information.
1.81%
Purchase this report to view the information.
1.7%
Purchase this report to view the information.
1.56%
Purchase this report to view the information.
1.48%
Subsidiaries
Beijing Watson Innovation Biotechnology Co., Ltd.
100%
Beijing Weida Biotechnology Co., Ltd.
100%
Guangdong Watson Pharmaceutical Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-19.73%▼
Total operating revenue
-11.65%▼
Operating profit (EBIT)
-50.94%▼
Net Profit (Loss) for the Period
-70.48%▼
Total Assets
-11.68%▼
Total Equity
-6.71%▼
Operating Profit Margin (ROS)
-5.19%▼
Net Profit Margin
-10.36%▼
Return on Equity (ROE)
-2.04%▼
Debt/Equity
-3.57%▼
Quick Ratio
0.48%▲
Cash Ratio
-0.52%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Heilongjiang Zbd Pharmaceutical Co.,Ltd.
 
Yabao Pharmaceutical Group Co.,Ltd
Pacific Shuanglin Bio-Pharmacy Co., Ltd
 
Shenzhen Kangtai Biological Products Co.,Ltd.
Zhejiang Tianyu Pharmaceutical Co., Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo